Use of adjuvant pharmacotherapy in type 1 diabetes: International comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries

Sarah K. Lyons, Julia M. Hermann, Kellee M. Miller*, Sabine E. Hofer, Nicole C. Foster, Birgit M. Rami-Merhar, Grazia Aleppo, Jochen Seufert, Linda A. DiMeglio, Thomas Danne, David M. Maahs, Reinhard W. Holl

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

45 Scopus citations
Original languageEnglish (US)
Pages (from-to)e139-e140
JournalDiabetes care
Volume40
Issue number10
DOIs
StatePublished - Oct 1 2017

Funding

Funding. The T1D Exchange is supported through the Leona M. and Harry B. Helmsley Charitable Trust. The DPV is supported through the German Federal Ministry of Education and Research (BMBF) Competence Network Diabetes Mellitus (FKZ 01GI1106), which was integrated into the German Center for Diabetes Research (DZD) as of January 2015. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. S.K.L. contributed to data interpretation and wrote and edited the manuscript. J.M.H. performed statistical analysis and contributed to data interpretation. K.M.M., S.E.H., N.C.F., B.M.R.-M., G.A., J.S., L.A.D., T.D., D.M.M., and R.W.H. contributed to data interpretation and reviewed and edited the manuscript. R.W.H. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis.

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this